Valerion Announces Biggest Black Friday Deals of the Year with Savings Up to $2,698
NEW YORK, Nov. 26, 2025 /PRNewswire/ -- Valerion, a leading specialist in home cinema projectors and the premium sub-brand of AWOL Vision, today announced its Black Friday and Cyber Monday promotion, offering savings of up to $2,698 across its...
SuperX Announces $20 Million Share Repurchase Program Authorization
SINGAPORE, Nov. 26, 2025 /PRNewswire/ -- SuperX AI Technology Limited (NASDAQ: SUPX) ("the Company" or "SuperX") today announced that its Board of Directors has authorized a share repurchase program under which the Company may repurchase up to $20...
Cheetah Mobile Announces Third Quarter 2025 Unaudited Consolidated Financial Results
BEIJING, Nov. 26, 2025 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), a China-based IT company, today announced its unaudited consolidated financial results for the quarter ended September 30, 2025. Management...
F+L Week 2026 Announces Initial Line-Up of Confirmed Speakers March 26-27, 2026 | The St. Regis Bangkok, Thailand
BANGKOK, Nov. 26, 2025 /PRNewswire/ -- F&L Asia Ltd. is pleased to announce the initial line-up of confirmed speakers for F+L Week 2026, the region's premier conference for the fuels, lubricants, energy, and mobility industries. The 2026 event...
Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal
Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy of ZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-dominant Crohn's disease (CD) Findings support the...
Gaotu Techedu Announces Third Quarter 2025 Unaudited Financial Results
BEIJING, Nov. 26, 2025 /PRNewswire/ -- Gaotu Techedu Inc. (NYSE: GOTU) ("Gaotu" or the "Company"), a leading technology-driven education company in China focused on enabling lifelong learning through AI-powered solutions, today announced its...
Renalys Pharma Announces Positive Topline Results from Phase III Study of Sparsentan in Japanese Patients with IgA Nephropathy
– In a Phase 3 clinical study evaluating the efficacy and safety of sparsentan in Japanese patients with IgA nephropathy (N=35), the percent change from baseline in the 24-hour urine protein-to-creatinine ratio at Week 36, which was the study's...
Korea Innovation Foundation selects 2 Innovative bio health companies, LEEBIO, and Airlab for Global Technology Commercialization Support Program (North America)
DAEJEON, South Korea, Nov. 26, 2025 /PRNewswire/ -- Korea Innovation Foundation (INNOPOLIS), currently operating the 2025 Global Technology Commercialization Support Program (North America), announces that 2 innovative companies, LEEBIO, and Airlab...
DESLOC Smart Lock Unveils the World's First Self-Sustained Perovskite Solar Door Lock, Debuting at CES 2026
DESLOC V150 Plus: The World's First Self-Sustaining Solar Smart Lock, Powered by a Built-in 4.8" Industry-Leading Perovskite Solar Panel SAN FRANCISCO, Nov. 26, 2025 /PRNewswire/ -- DESLOC Smart Lock proudly announces the world's first smart lock...
China Dongxiang Announces FY2025/26 Interim Results
Resilient Growth Across Dual Business Segments Driv es the Group's Steady Value Creation Results Highlights Revenue amounted to RMB748 million, representing broadly flat year-over-year (YoY); Gross profit amounted to RMB511 million, representing a...